The design of functional antagonists of the S1P, modulators with selective exposure to lymphatic tissue through directed gastro-intestinal uptake.

Project: Research

StatusFinished
Effective start/end date1/08/1131/07/12

Funding

  • Multiple Sclerosis Research Australia: AUD25,000.00